Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals (NQ: VNDA )

4.995 -0.145 (-2.82%)
Streaming Delayed Price Updated: 12:15 PM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vanda Pharmaceuticals

< Previous 1 2 3 4 Next >
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
VNDA Stock Earnings: Vanda Pharma Misses EPS, Misses Revenue for Q1 2024
VNDA stock results show that Vanda Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Legal battle details, implications, and market impact." 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The Dow traded up 0.04% to 37,813.77 while the NASDAQ fell 0.78% to 15,742.21.... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
Future Pak wants Vanda, but Vanda doesn't want Future Pak. 
Via The Motley Fool
Vanda Pharma: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Earnings Preview For Vanda Pharma
Via Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. Board asserts resilient business with FDA-approved products. Future Pak... 
Via Benzinga
Why Is Trio Petroleum (TPET) Stock Down 22% Today?
Trio Petroleum stock is falling on Wednesday as TPET investors learn of a securities purchase agreement and Senior Secured Note. 
Via InvestorPlace
Why Is Trilogy Metals (TMQ) Stock Down 29% Today?
Trilogy Metals stock is falling on Wednesday as TMQ investors react to reports that the government plans to block its Ambler Access Project. 
Via InvestorPlace
Why Is Vanda Pharmaceuticals (VNDA) Stock Up 34% Today?
Vanda Pharmaceuticals stock is heading higher on Wednesday as investors in VNDA learn of an acquisition offer for their shares. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday! 
Via InvestorPlace
Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3% on Wednesday. The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% to 16,315.68. The S&P 500 also... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly... 
Via Benzinga
Exposures Glyphosate
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Moves Higher; ISM Services PMI Falls In March
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.5% on Wednesday. The Dow traded up 0.18% to 39,241.00 while the NASDAQ rose 0.55% to 16,329.45. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
EDR Stock Alert: Endeavor Group Is Going Private for $13 Billion
Endeavor Group stock is on the move Wednesday as EDR holders react to news of Silver Lake taking the sports and entertainment company private. 
Via InvestorPlace
Costco Weight Loss Program: How You Can Get Ozempic From Costco
Costco is offering a new weight loss program for subscribers that may also include prescriptions for weight loss drug Ozempic. 
Via InvestorPlace
Why Is Vanda Pharmaceuticals (VNDA) Stock Up 33% Today?
Vanda Pharmaceuticals stock is rising higher on Wednesday as investors in VNDA celebrate FDA approval of its bipolar treatment. 
Via InvestorPlace
Exposures Product Safety
Why Is Vanda Pharmaceuticals Stock Trading Higher Today?
FDA approves Vanda Pharmaceuticals' Fanapt tablets for bipolar I disorder manic or mixed episodes in adults. Fanapt, an atypical antipsychotic, shows significant improvement over placebo in pivotal... 
Via Benzinga
Exposures Product Safety
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic this morning as we check out all of the biggest news worth reading about on Wednesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.